| Ytd | -86.79% | |
| 1y | -72.48% |
| Open | 1.44 | Prev Close | 1.38 | Low | 1.43 | High | 1.84 | Mkt Cap | 42.45M |
| Vol | 25.64M | Avg Vol | 2.23M | EPS | -1.48 | P/E | -1.08 | Forward P/E | -1.06 |
| Beta | 0.93 | Short Ratio | 1.46 | Inst. Own | 47.95% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 08-15 | 50-d Avg | 13.51 | 200-d Avg | 12.39 | 1yr Est | 16.30 |
TENX News
Tenax Therapeutics NASDAQ: TENX reported that its Phase III LEVEL trial of oral levosimendan in pati
Gainers Jin Medical International (NASDAQ:ZJYL) shares rose 58.1% to $3.4 during Monday's regul
US stocks mixed, Dow Jones down 0.2% midday. Energy shares up 3%, real estate down 1.4%. National En
Tenax Therapeutics Inc. (NASDAQ:TENX) stock is trading lower on Monday after the company reported to
Tenax Therapeutics, Inc. (TENX) Discusses Phase III LEVEL Trial Results for Oral Levosimendan in HFp
Gainers Jin Medical International (NASDAQ:ZJYL) stock rose 70.7% to $3.67 during Monday's pre-m
Summary: U.S. stock futures mixed, Dow futures down 0.1%. AirSculpt Technologies shares fell 13.4% a
Tenax Therapeutics said on Monday its experimental heart drug failed to meet the main goal of a
TNX-103 did not meet statistical significance on the primary endpoint of improvement in 6-minute wal
Tenax Therapeutics, Inc. (NASDAQ: TENX - Get Free Report) has received a consensus recommendation of
Company expects to report topline data from Phase 3 LEVEL clinical trial in August 2026 CHAPEL HILL,
The mean of analysts' price targets for Tenax Therapeutics (TENX) points to a 121.4% upside in the s
Tenax Therapeutics, Inc. is downgraded from Buy to Hold ahead of a major August 2026 phase 3 data re
CHAPEL HILL, N.C., July 02, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax
Rivian Automotive Inc (RIVN) gained 12.2% after strong Q2 production figures and raised delivery for
Gainers Liminatus Pharma (NASDAQ:LIMN) stock increased by 40.9% to $0.16 during Thursday's pre-
Abstract recently submitted in anticipation of initial data analysis ahead of ESC Company expects to
On track to report topline data from Phase 3 LEVEL study of TNX-103 in third quarter of 2026 Global
CHAPEL HILL, N.C., May 08, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tenax”
Mr. Healey is a seasoned pharmaceutical executive with a strong track record of successful commercia
Mr. Staab has over 25 years of financial and executive experience across the healthcare industry CHA
Tenax Therapeutics, Inc. (NASDAQ: TENX - Get Free Report) passed above its two hundred day moving av
Shares of Tenax Therapeutics, Inc. (NASDAQ: TENX - Get Free Report) crossed above its 200-day moving
Achieved randomization target of 230 patients in LEVEL study, topline data expected in third quarter
Tenax Therapeutics (NASDAQ: TENX - Get Free Report) and Gyre Therapeutics (NASDAQ: GYRE - Get Free R
CHAPEL HILL, N.C., March 03, 2026 (GLOBE NEWSWIRE) -- Tenax Therapeutics, Inc. (Nasdaq: TENX) (“Tena
Gainers Aridis Pharmaceuticals, Inc. (NASDAQ: ARDS) shares jumped 143% to $0.45 after the company
On Wednesday, 345 companies set new 52-week lows.
On Monday, 147 stocks made new 52-week lows.
On Wednesday, 220 stocks hit new 52-week lows.
On Monday, 76 companies set new 52-week lows.
On Wednesday, 116 companies set new 52-week lows.
On Tuesday, 93 companies set new 52-week lows.
Monday saw 825 companies set new 52-week lows.
Gainers AMTD Digital Inc. (NYSE: HKD) shares jumped 311.8% to settle at $189.42 on Wednesday as t
On Tuesday, 400 companies set new 52-week lows.
Gainers USA Truck, Inc. (NASDAQ: USAK) shares climbed 112.6% to close at $31.00 on Friday. DB Sc
Tuesday's session saw 729 companies set new 52-week lows.
During Friday's session, 445 companies made new 52-week lows.
41 Biggest Movers From Yesterday
Stocks Which Set New 52-Week Low The Last Trading Session, Wed., Nov. 21, 2018
28 Stocks Moving In Monday's Pre-Market Session